4//SEC Filing
Sensenig Bethany 4
Accession 0001628280-25-040668
CIK 0001356576other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 4:31 PM ET
Size
5.4 KB
Accession
0001628280-25-040668
Insider Transaction Report
Form 4
Sensenig Bethany
Director
Transactions
- Sale
Common Stock
2025-08-14$42.25/sh−5,369$226,840→ 0 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted May 15, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.88 to $42.52. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001899935
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 4:31 PM ET
- Size
- 5.4 KB